Alterations in the expression of various genes, such as EGFR, ALK, ROS1, KRAS, and BRAF, play essential roles in NSCLC, and these genes serve as targets of chemotherapy [56]. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.